Phathom Pharmaceuticals (PHAT) Financial Statements
Price: $4.88
Market Cap: $339.83M
Avg Volume: 1.21M
Market Cap: $339.83M
Avg Volume: 1.21M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Phathom Pharmaceuticals.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $55.25M | $682.00K | $- | $- | $- | $- | $- |
| Cost of Revenue | $7.97M | $167.00K | $620.00K | $521.00K | $300.00K | $8.00K | $- |
| Gross Profit | $47.28M | $515.00K | $-620.00K | $-521.00K | $-300.00K | $-8.00K | $- |
| Gross Profit Ratio | 85.57% | 75.51% | - | - | - | - | 0.00% |
| Research and Development Expenses | $34.08M | $49.90M | $71.44M | $72.34M | $98.15M | $99.27M | $20.00K |
| General and Administrative Expenses | $- | $- | $101.00M | $62.74M | $27.52M | $6.94M | $1.21M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $290.66M | $117.93M | $101.00M | $62.74M | $27.52M | $6.94M | $1.21M |
| Other Expenses | $- | $- | $-110.00K | $-2.06M | $-8.00K | $-49.56M | $-50.00K |
| Operating Expenses | $324.75M | $167.83M | $172.44M | $135.08M | $125.67M | $106.22M | $1.23M |
| Cost and Expenses | $332.72M | $167.99M | $172.44M | $135.08M | $125.67M | $106.22M | $1.23M |
| Interest Income | $15.16M | $7.88M | $2.13M | $41.00K | $1.09M | $1.09M | $- |
| Interest Expense | $72.01M | $41.97M | $27.30M | $6.79M | $4.58M | $4.18M | $13.00K |
| Depreciation and Amortization | $795.00K | $575.00K | $620.00K | $521.00K | $300.00K | $8.00K | $1.23M |
| EBITDA | $-261.52M | $-159.05M | $-171.82M | $-134.56M | $-124.19M | $-250.95M | $-50.00K |
| EBITDA Ratio | -473.33% | -23320.97% | - | - | - | - | - |
| Operating Income | $-277.47M | $-167.31M | $-172.44M | $-135.08M | $-125.67M | $-106.22M | $-1.23M |
| Operating Income Ratio | -502.18% | -24532.55% | - | - | - | - | - |
| Total Other Income Expenses Net | $-56.86M | $-34.28M | $-25.28M | $-8.80M | $-3.40M | $-148.92M | $-63.00K |
| Income Before Tax | $-334.33M | $-201.59M | $-197.72M | $-143.88M | $-129.07M | $-255.13M | $-1.29M |
| Income Before Tax Ratio | -605.09% | -29558.94% | - | - | - | - | - |
| Income Tax Expense | $- | $- | $25.28M | $4.21M | $4.25M | $-45.39M | $13.00K |
| Net Income | $-334.33M | $-201.59M | $-223.01M | $-148.09M | $-133.32M | $-209.74M | $-1.29M |
| Net Income Ratio | -605.09% | -29558.94% | - | - | - | - | - |
| EPS | $-5.29 | $-3.93 | $-5.70 | $-4.00 | $-4.01 | $-8.48 | $-0.15 |
| EPS Diluted | $-5.29 | $-3.93 | $-5.70 | $-4.00 | $-4.01 | $-8.48 | $-0.15 |
| Weighted Average Shares Outstanding | 63.18M | 51.29M | 39.12M | 37.00M | 33.23M | 24.73M | 8.58M |
| Weighted Average Shares Outstanding Diluted | 63.18M | 51.29M | 39.12M | 37.00M | 33.23M | 24.73M | 8.58M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $297.26M | $381.39M | $155.38M | $183.26M | $287.50M | $243.76M | $879.00K |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $297.26M | $381.39M | $155.38M | $183.26M | $287.50M | $243.76M | $879.00K |
| Net Receivables | $38.80M | $1.64M | $- | $- | $82.00K | $- | $- |
| Inventory | $3.21M | $1.21M | $- | $- | $-82.00K | $- | $- |
| Other Current Assets | $20.87M | $13.19M | $10.25M | $6.53M | $7.74M | $23.67M | $4.00K |
| Total Current Assets | $360.13M | $397.43M | $160.51M | $186.53M | $291.37M | $255.60M | $902.00K |
| Property Plant Equipment Net | $2.09M | $3.62M | $3.49M | $2.56M | $3.36M | $1.40M | $- |
| Goodwill | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $505.00K | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $16.09M | $12.79M | $299.00K | $341.00K | $384.00K | $181.00K | $- |
| Total Non-Current Assets | $18.18M | $16.41M | $4.30M | $2.90M | $3.74M | $1.58M | $- |
| Other Assets | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $378.32M | $413.84M | $164.81M | $189.43M | $295.11M | $257.18M | $902.00K |
| Account Payables | $10.51M | $12.60M | $10.00M | $5.15M | $16.78M | $699.00K | $55.00K |
| Short Term Debt | $1.00M | $726.00K | $1.42M | $974.00K | $8.30M | $322.00K | $1.95M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $2.48M | $-1.95M |
| Other Current Liabilities | $74.22M | $25.45M | $14.82M | $12.80M | $30.44M | $2.73M | $183.00K |
| Total Current Liabilities | $85.73M | $38.78M | $26.24M | $18.92M | $55.52M | $3.75M | $2.19M |
| Long Term Debt | $- | $138.30M | $96.36M | $90.85M | $41.19M | $23.41M | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $546.17M | $309.52M | $117.03M | $7.50M | $4.12M | $2.06M | $- |
| Total Non-Current Liabilities | $546.17M | $447.82M | $213.39M | $98.35M | $45.32M | $25.48M | $- |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $631.90M | $486.60M | $239.62M | $117.28M | $100.84M | $29.22M | $2.19M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $6.00K | $5.00K | $3.00K | $3.00K | $3.00K | $2.00K | $- |
| Retained Earnings | $-1.26B | $-928.68M | $-727.09M | $-529.37M | $-385.49M | $-256.42M | $-1.29M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $0 | $- | $- |
| Other Total Stockholders Equity | $1.01B | $855.92M | $652.28M | $601.52M | $579.75M | $484.37M | $2.00K |
| Total Stockholders Equity | $-253.58M | $-72.76M | $-74.81M | $72.16M | $194.27M | $227.96M | $-1.29M |
| Total Equity | $-253.58M | $-72.76M | $-74.81M | $72.16M | $194.27M | $227.96M | $-1.29M |
| Total Liabilities and Stockholders Equity | $378.32M | $413.84M | $164.81M | $189.43M | $295.11M | $257.18M | $902.00K |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $378.32M | $413.84M | $164.81M | $189.43M | $295.11M | $257.18M | $902.00K |
| Total Investments | $- | $2.86M | $505.00K | $- | $- | $- | $- |
| Total Debt | $501.00K | $139.03M | $97.07M | $91.34M | $49.02M | $23.57M | $1.95M |
| Net Debt | $-296.76M | $-242.36M | $-58.31M | $-91.92M | $-238.48M | $-220.19M | $1.07M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Net Income | $-334.33M | $-201.59M | $-197.72M | $-143.88M | $-129.07M | $-255.13M | $-1.29M |
| Depreciation and Amortization | $795.00K | $575.00K | $620.00K | $521.00K | $323.00K | $8.00K | $- |
| Deferred Income Tax | $- | $- | $- | $- | $-95.00K | $96.27M | $- |
| Stock Based Compensation | $24.05M | $45.02M | $24.13M | $16.81M | $5.84M | $406.00K | $- |
| Change in Working Capital | $- | $-13.64M | $5.44M | $-27.48M | $51.72M | $-9.52M | $215.00K |
| Accounts Receivables | $-37.16M | $-1.64M | $- | $- | $- | $- | $- |
| Inventory | $836.00K | $-9.44M | $- | $- | $- | $- | $- |
| Accounts Payables | $34.94M | $6.41M | $8.68M | $-9.79M | $24.01M | $2.27M | $225.00K |
| Other Working Capital | $- | $-8.97M | $-3.24M | $-17.68M | $27.71M | $-11.79M | $-10.00K |
| Other Non Cash Items | $42.71M | $32.06M | $21.00M | $5.41M | $1.59M | $131.46M | $50.00K |
| Net Cash Provided by Operating Activities | $-266.77M | $-137.58M | $-146.53M | $-148.62M | $-69.69M | $-36.51M | $-1.02M |
| Investments in Property Plant and Equipment | $- | $-1.63M | $-1.04M | $-328.00K | $-1.04M | $-25.25M | $- |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-135.00K | $- | $-1.18M | $-330.00K | $-1.19M | $-25.12M | $- |
| Net Cash Used for Investing Activities | $-135.00K | $-1.63M | $-1.04M | $-328.00K | $-1.04M | $-25.25M | $- |
| Debt Repayment | $59.40M | $39.32M | $- | $42.76M | $25.00M | $24.85M | $1.90M |
| Common Stock Issued | $121.78M | $155.46M | $24.60M | $1.29M | $88.83M | $191.47M | $2.00K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $1.60M | $172.80M | $95.45M | $1.94M | $629.00K | $279.80M | $2.00K |
| Net Cash Used Provided by Financing Activities | $182.77M | $367.58M | $120.04M | $44.71M | $114.46M | $304.65M | $1.90M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-84.13M | $228.37M | $-27.53M | $-104.24M | $43.73M | $242.89M | $879.00K |
| Cash at End of Period | $300.12M | $384.26M | $155.89M | $183.26M | $287.50M | $243.76M | $879.00K |
| Cash at Beginning of Period | $384.26M | $155.89M | $183.42M | $287.50M | $243.76M | $879.00K | $- |
| Operating Cash Flow | $-266.77M | $-137.58M | $-146.53M | $-148.62M | $-69.69M | $-36.51M | $-1.02M |
| Capital Expenditure | $- | $-1.63M | $-1.04M | $-328.00K | $-1.04M | $-25.25M | $- |
| Free Cash Flow | $-266.77M | $-139.21M | $-147.57M | $-148.94M | $-70.73M | $-61.76M | $-1.02M |